Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole

Don Hayes1, Amanda M Ball, Heidi M Mansour

  • 1University of Kentucky, Lexington, KY, USA. don.hayes@uky.edu

Abstract

Insights

Single-agent antifungal prophylaxis with itraconazole did not alter fungal infection rates in heart and lung transplant patients. Infections increased with immunosuppression escalation for acute rejection.

Area of Science:

  • Transplant medicine
  • Infectious diseases
  • Pharmacology

Background:

  • Heart and lung transplant recipients face a high risk of invasive fungal infections.
  • Antifungal prophylaxis is crucial in managing post-transplant complications.

Purpose of the Study:

  • To evaluate the impact of single-agent itraconazole prophylaxis on fungal infection rates in heart and lung transplant recipients.
  • To assess the efficacy of itraconazole in preventing invasive fungal infections post-transplant.

Main Methods:

  • Observational, retrospective study design.
  • Evaluation of 4.5 years of data from heart and lung transplant recipients at the University of Kentucky Medical Center.
  • Analysis of fungal infection incidence in patients receiving itraconazole prophylaxis.

Main Results:

  • Overall fungal infection incidence was 16.9% (14/83) across both groups.
  • Heart transplant recipients had an 11.9% incidence (5/42), while lung recipients had a 22.0% incidence (9/41).
  • No significant change in fungal infection rates was observed compared to historical data.

Conclusions:

  • Single-agent itraconazole prophylaxis did not significantly affect fungal infection rates in heart or lung transplant recipients.
  • A notable increase in fungal infections occurred within 3 months of escalating immunosuppression for acute rejection.
  • Further strategies may be needed to manage fungal infections in this vulnerable population.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: